ClearBridge Investments’s BioNTech BNTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,000
Closed -$213K 719
2025
Q2
$213K Buy
+2,000
New +$202K ﹤0.01% 699
2025
Q1
Sell
-1,800
Closed -$205K 708
2024
Q4
$205K Sell
1,800
-100
-5% -$11.4K ﹤0.01% 710
2024
Q3
$226K Buy
+1,900
New +$175K ﹤0.01% 702
2024
Q2
Sell
-361,813
Closed -$33.4M 738
2024
Q1
$33.4M Sell
361,813
-144,879
-29% -$13.9M 0.03% 393
2023
Q4
$53.5M Buy
506,692
+22,566
+5% +$2.27M 0.05% 322
2023
Q3
$52.6M Buy
484,126
+142,344
+42% +$15.7M 0.05% 297
2023
Q2
$36.9M Buy
341,782
+90,306
+36% +$10.2M 0.03% 363
2023
Q1
$31.3M Buy
+251,476
New +$34.5M 0.03% 387

Other funds holding BNTX

ClearBridge Investments's BNTX Position: Q3 2025 in Review

ClearBridge Investments sold out of BioNTech (BNTX) in Q3 2025, closing a stake of 2,000 shares — an estimated $213K sold.

ClearBridge Investments first reported a position in BNTX in Q1 2023 and held it in 8 quarters. The position peaked at $53.5M in Q4 2023. 254 funds tracked by Wall St. Rank hold BNTX as of Q3 2025.

  • ClearBridge Investments reported no remaining BioNTech position as of Q3 2025 after selling out during the quarter.
  • ClearBridge Investments sold 2,000 BioNTech shares in Q3 2025, an estimated $213K.
  • ClearBridge Investments first reported a position in BioNTech in Q1 2023 and held it in 8 quarters.
  • ClearBridge Investments's BioNTech position peaked at $53.5M in Q4 2023.
  • 254 funds tracked by Wall St. Rank held BioNTech as of Q3 2025.

Based on ClearBridge Investments's 13F filing for Q3 2025, filed 13 Nov 2025.